These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8546206)

  • 21. Stem cell factor augments Fc epsilon RI-mediated TNF-alpha production and stimulates MAP kinases via a different pathway in MC/9 mast cells.
    Ishizuka T; Kawasome H; Terada N; Takeda K; Gerwins P; Keller GM; Johnson GL; Gelfand EW
    J Immunol; 1998 Oct; 161(7):3624-30. PubMed ID: 9759885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abrogation of c-kit/Steel factor-dependent tumorigenesis by kinase defective mutants of the c-kit receptor: c-kit kinase defective mutants as candidate tools for cancer gene therapy.
    Li Q; Kondoh G; Inafuku S; Nishimune Y; Hakura A
    Cancer Res; 1996 Oct; 56(19):4343-6. PubMed ID: 8813120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem cell factor-induced downregulation of c-kit in human lung mast cells and HMC-1 mast cells.
    Baghestanian M; Agis H; Bevec D; Bankl HC; Hofbauer R; Kress HG; Butterfield JH; Müller MR; Ashman LK; Füreder W; Willheim M; Lechner K; Valent P
    Exp Hematol; 1996 Oct; 24(12):1377-86. PubMed ID: 8913283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase.
    Kitayama H; Tsujimura T; Matsumura I; Oritani K; Ikeda H; Ishikawa J; Okabe M; Suzuki M; Yamamura K; Matsuzawa Y; Kitamura Y; Kanakura Y
    Blood; 1996 Aug; 88(3):995-1004. PubMed ID: 8704259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the cAMP and MAPK pathways in the transformation of mouse 3T3 fibroblasts by a TSHR gene constitutively activated by point mutation.
    Du Villard JA; Wicker R; Crespo P; Russo D; Filetti S; Gutkind JS; Sarasin A; Suárez HG
    Oncogene; 2000 Oct; 19(42):4896-905. PubMed ID: 11039907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucocorticoids inhibit the cytokine-induced proliferation of mast cells, the high affinity IgE receptor-mediated expression of TNF-alpha, and the IL-10-induced expression of chymases.
    Eklund KK; Humphries DE; Xia Z; Ghildyal N; Friend DS; Gross V; Stevens RL
    J Immunol; 1997 May; 158(9):4373-80. PubMed ID: 9127001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Constitutive activation of c-kit in FMA3 murine mastocytoma cells caused by deletion of seven amino acids at the juxtamembrane domain.
    Tsujimura T; Morimoto M; Hashimoto K; Moriyama Y; Kitayama H; Matsuzawa Y; Kitamura Y; Kanakura Y
    Blood; 1996 Jan; 87(1):273-83. PubMed ID: 8547652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of immature mast cells in the skin of Ws/Ws rats with a small deletion at tyrosine kinase domain of the c-kit gene.
    Onoue H; Maeyama K; Nomura S; Kasugai T; Tei H; Kim HM; Watanabe T; Kitamura Y
    Am J Pathol; 1993 Apr; 142(4):1001-7. PubMed ID: 7682755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deficient differentiation of mast cells in the skin of mi/mi mice. Usefulness of in situ hybridization for evaluation of mast cell phenotype.
    Kasugai T; Oguri K; Jippo-Kanemoto T; Morimoto M; Yamatodani A; Yoshida K; Ebi Y; Isozaki K; Tei H; Tsujimura T
    Am J Pathol; 1993 Nov; 143(5):1337-47. PubMed ID: 8238251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of constitutive activation of c-kit receptor tyrosine kinase.
    Tsujimura T; Kanakura Y; Kitamura Y
    Leukemia; 1997 Apr; 11 Suppl 3():396-8. PubMed ID: 9209403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A point mutation in the extracellular domain of KIT promotes tumorigenesis of mast cells via ligand-independent auto-dimerization.
    Amagai Y; Matsuda A; Jung K; Oida K; Jang H; Ishizaka S; Matsuda H; Tanaka A
    Sci Rep; 2015 May; 5():9775. PubMed ID: 25965812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the c-kit gene product in normal and neoplastic mast cells but not in neoplastic basophil/mast cell precursors from chronic myelogenous leukaemia.
    Fukuda T; Kamishima T; Tsuura Y; Suzuki T; Kakihara T; Naito M; Kishi K; Matsumoto K; Shibata A; Seito T
    J Pathol; 1995 Oct; 177(2):139-46. PubMed ID: 7490680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3.
    Tsujimura T; Furitsu T; Morimoto M; Kanayama Y; Nomura S; Matsuzawa Y; Kitamura Y; Kanakura Y
    Int Arch Allergy Immunol; 1995 Apr; 106(4):377-85. PubMed ID: 7536501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Constitutive c-myc expression enhances the response of murine mast cells to IL-3, but does not eliminate their requirement for growth factors.
    Hume CR; Nocka KH; Sorrentino V; Lee JS; Fleissner E
    Oncogene; 1988 Mar; 2(3):223-6. PubMed ID: 3281092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constitutively active mutant D816VKit induces megakayocyte and mast cell differentiation of early haemopoietic cells from murine foetal liver.
    Ferrao PT; Gonda TJ; Ashman LK
    Leuk Res; 2003 Jun; 27(6):547-55. PubMed ID: 12648515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular genetics and development of mast cells: implications for molecular medicine.
    Födinger M; Mannhalter C
    Mol Med Today; 1997 Mar; 3(3):131-7. PubMed ID: 9095488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of c-kit receptor tyrosine kinase in the development, survival and neoplastic transformation of mast cells.
    Tsujimura T
    Pathol Int; 1996 Dec; 46(12):933-8. PubMed ID: 9110344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clustering of activating mutations in c-KIT's juxtamembrane coding region in canine mast cell neoplasms.
    Ma Y; Longley BJ; Wang X; Blount JL; Langley K; Caughey GH
    J Invest Dermatol; 1999 Feb; 112(2):165-70. PubMed ID: 9989791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low c-kit expression of cultured mast cells of mi/mi genotype may be involved in their defective responses to fibroblasts that express the ligand for c-kit.
    Ebi Y; Kanakura Y; Jippo-Kanemoto T; Tsujimura T; Furitsu T; Ikeda H; Adachi S; Kasugai T; Nomura S; Kanayama Y
    Blood; 1992 Sep; 80(6):1454-62. PubMed ID: 1381628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KIT-D816V oncogenic activity is controlled by the juxtamembrane docking site Y568-Y570.
    Chaix A; Arcangeli ML; Lopez S; Voisset E; Yang Y; Vita M; Letard S; Audebert S; Finetti P; Birnbaum D; Bertucci F; Aurrand-Lions M; Dubreuil P; De Sepulveda P
    Oncogene; 2014 Feb; 33(7):872-81. PubMed ID: 23416972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.